Radiotherapeutic management of osseous metastases: A survey of current patterns of care

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 4, 1998, Pages 915-921

  Ben Josef, Edgar ^a   Shamsa, Falah ^a   Williams, Aaron O ^a   Porter, Arthur T ^a  

^a KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Bone metastases; Hemibody radiotherapy; Palliative care; Radiotherapy; Strontium 89; Systemic Radionuclides

Indexed keywords

ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE METASTASIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; HUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION FIELD;

BONE NEOPLASMS; HEALTH CARE SURVEYS; HEMIBODY IRRADIATION; HUMANS; PAIN; PALLIATIVE CARE; QUESTIONNAIRES; RADIATION ONCOLOGY; UNITED STATES;

EID: 0031899932     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00927-9     Document Type: Article

References (23)

1. Foley K. M. The treatment of cancer pain. N. Engl. J. Med. 313:1985;84-94.
2. Malawer M. M., Delanet T. F. Treatment of metastatic cancer to bone. Devita V. T., Hellman S., Rosenberg S. A. Cancer Principles and practice of oncology . 4th ed. 1993;2225-2244 J.B. Lipincott, Philadelphia.
3. Cleeland C. S., Gonin R., Hatfield A. K., et al. Pain and its treatment in outpatients with metastatic cancer. N. Engl. J. Med. 330:1994;592-596.
4. Von Roenn J. H., Cleeland C. S., Gonin R., Hatfield A. K., Pandya K. J. Physician attitudes and practice in cancer pain management - a survey from the Eastern Cooperative Oncology Group. Ann. Intern. Med. 119:1993;121-126.
5. Tong D., Gillick L., Hendrickson F. R. The palliation of symptomatic osseous metastases Final results of the study by the Radiation Therapy Oncology Group . Cancer. 50:1982;893-899.
6. Hoskin P. J., Price P., Easton D., et al. A prospective randomized trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother. Oncol. 23:1992;74-78.
7. Price P., Hoskin P. J., Easton D., et al. Prospective randomized trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother. Oncol. 6:1986;247-255.
8. Salazar O. M., Rubin P. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Cancer. 58:1986;29-36.
9. Poulter C. A., Cosmatos D., Rubin P., et al. A report of RTOG 8206 A phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases . Int. J. Radiat. Oncol. Biol. Phys. 23:1992;207-214.
10. Johnson R. A., Wichern D. W. Applied multivariate statistical analysis. 2nd ed. 1988;190-209 Prentice Hall, Englewood Cliffs, NJ.
11. Hoskin P. J. Scientific and clinical aspects of radiotherapy in the relief of bone pain. Cancer Surv. 7:1988;69.
12. Blitzer P. Reanalysis of the RTOG study of the palliation of asymptomatic osseous metastases. Cancer. 55:1985;1468-1472.
13. Quilty P. M., Kirk D., Bolger J. J., Dearnaley D. P., Lewington V. J., Mason M. D., Reed N. S., Russell J. M., Yardely J. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother. Oncol. 31:1994;33-40.
14. Porter A. T., McEwan A. J. B., Powe J. E., Reid R., McGowan D. G., Lukka H., Sathyanarayana J. R., Yakemchuk V. N., Thomas G. M., Erlich L. E., et al. Results of a randomized phase- III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 25:1993;805-813.
15. Ben-Josef E., Lucas R. D., Vasan S., Porter A. T. Selective accumulation of strontium-89 in metastatic deposits in bone Radio-histological correlation . Nucl. Med. Commun. 16:1995;457-463.
16. Blake G. M., Zivanovic M. A., McEwan A. J., et al. Sr-89 therapy Strontium kinetics in disseminated carcinoma of the prostate . Eur. J. Nucl. Med. 12:1986;447-454.
17. Breen S. L., Powe J. E., Porter A. T. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma. J. Nucl. Med. 33:1992;1316-1323.
18. Laing A. H., Ackery D. M., Bayly R. J., et al. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br. J. Radiol. 64:1991;816-822.
19. Lewington V. J., McEwan A. J., Ackery D. M., et al. A prospective randomized double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur. J. Cancer. 27:1991;954-958.
20. Fitzpatrick P. J. Wide-field irradiation of bone metastases. Weiss L., Gilbert H. A. Bone metastases. 1981;83-113 GK Hall, Boston.
21. Rowland C. G., Bullimore J. A., Smith P. J. B., Roberts J. B. M. Half body irradiation in the treatment of metastatic prostatic carcinoma. Br. J. Urol. 53:1981;628-629.
22. Qasim M. M. Half body irradiation in the treatment of metastatic carcinomas. Clin. Radiol. 32:1981;215-219.
23. Wilkins M. F., Keen C. W. Hemibody radiotherapy in the management of metastatic carcinoma. Clin. Radiol. 38:1987;267-268.